First Light Asset Management, LLC Cellectis S.A. Transaction History

First Light Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 14, 2019	SELL	$10.15 - $16.89 $769,806 - $1.28 Million	-75,843 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$14.6 - $20.6 $6,263 - $8,837	429 Added 0.57%	75,843 $1.18 Million
Q1 2019 May 15, 2019	BUY	$15.53 - $19.75 $763,765 - $971,305	49,180 Added 187.47%	75,414 $1.38 Million
Q4 2018 Feb 14, 2019	SELL	$15.58 - $28.41 $780,417 - $1.42 Million	-50,091 Reduced 65.63%	26,234 $437,000
Q3 2018 Nov 14, 2018	BUY	$25.99 - $30.6 $1.98 Million - $2.34 Million	76,325 New	76,325 $2.15 Million

9.73M

30.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $101M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of First Light Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on First Light Asset Management, LLC with notifications on news.